Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 15 May 2024 11:39:27 +0200Tue, 20 Feb 2024 16:40:00 +0100Human medicines European public assessment report (EPAR): Adrovance, alendronic acid,colecalciferol, Date of authorisation: 04/01/2007, Revision: 26, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/adrovanceHuman medicines European public assessment report (EPAR): Adrovance, alendronic acid,colecalciferol, Date of authorisation: 04/01/2007, Revision: 26, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/adrovanceTue, 20 Feb 2024 16:40:00 +0100Human medicineAdrovance : EPAR - Scientific Discussionhttps://www.ema.europa.eu/system/files/documents/scientific-discussion/wc500022041_en.pdfAdrovance : EPAR - Scientific Discussionhttps://www.ema.europa.eu/system/files/documents/scientific-discussion/wc500022041_en.pdfThu, 18 Jan 2007 01:00:00 +0100Human medicine